A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2004
11/03/2004	CN1173976C Use of antineoplastic active compound nitrene-phin
11/03/2004	CN1173974C Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist
11/03/2004	CN1173973C Benzocarbazole and indenoindole derived estrogenic agents
11/03/2004	CN1173972C Azaring-ether derivatives and their use as nicotinic ach receptor modulators
11/03/2004	CN1173971C Cycloalkyl-substituted aminomethylpyrrolidine derivatives
11/03/2004	CN1173970C Tetrahydroquinoline derivatives as glycine antagonists
11/03/2004	CN1173969C Novel lipoic acid derivatives, their preparation method and medical use, and pharmaceutical compositions containing them
11/03/2004	CN1173968C Production method of halogenated hexahydroxydiphenic derivative and its medicinal application
11/03/2004	CN1173967C Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
11/03/2004	CN1173964C Novel benzofuranone derivative and process for producing same
11/03/2004	CN1173959C 8,8A-dihydro-indeno [1,2-D] thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament
11/03/2004	CN1173958C Compound capable of inhibiting thrombocyte agglutination and resisting thrombosis and its preparation and application
11/03/2004	CN1173957C Substituted piperazones and their therapeutic use
11/03/2004	CN1173956C Novel piperazinylalkyl thiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of same
11/03/2004	CN1173953C Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
11/03/2004	CN1173951C Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use
11/03/2004	CN1173950C 2,3-Disubstituted pyridine derivatives, process for preparation thereof, drug compositions containing the same and intermediates for preparation
11/03/2004	CN1173948C Alpha-substituted arylsulphonamido hydroxamic acids as TNF-alpha and matrix metalloproteinase inhibitors
11/03/2004	CN1173945C 5-thia-omega-substituted phenyl-prostaglandin E derivatives, process for producing same and drugs containing same as active ingredient
11/03/2004	CN1173944C New vitamin-D derivatives with carbon ring or heterocyclic substitutents at C-25, process for the preparation, intermediate products and their use for producing medicaments
11/03/2004	CN1173934C N-acetoacetarylamides
11/03/2004	CN1173929C Process for preparing adrenin beta-excitomotors by combinaion and disconnection method
11/03/2004	CN1173928C Process for preparing (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof
11/03/2004	CN1173926C Substituted 2-phenyl-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system and pharmaceutical compositions containing them
11/03/2004	CN1173909C 20 kinds of modified vitamin D series derivatives, preparing and drug thereof
11/03/2004	CN1173745C Use of chemically modified methioninase in anti-methionine and anti-homocysteine chemotherapy
11/03/2004	CN1173743C Compositions for treatment of disorders of the oesophagus
11/03/2004	CN1173742C Sustained release medicinal compositions
11/03/2004	CN1173721C External-use ointment
11/03/2004	CN1173720C Tradtional Chinese prepared medicine for stopping pain and abstaining from drugs
11/03/2004	CN1173711C Donkey-hide gelatin capsule
11/03/2004	CN1173710C Treatment of congestive heart failure by pretreated autologous blood
11/03/2004	CN1173708C Preparation method of povidone-iodine
11/03/2004	CN1173707C Medicinal composition containing baicalin and caffoeoylchinic acid
11/03/2004	CN1173706C Application of N-acetyl-D-aminoglucose in preparing medicines to treat cervical erosion
11/03/2004	CN1173705C Use of ª‰-2-hydroxymethyl-5-(5-fluctyosine-1-yl)-1,3-oxathialane in preparation of medicine and composition containing same
11/03/2004	CN1173704C Use of ibandronate for promoting osseocicatrization of endoprosthesis
11/03/2004	CN1173703C Pharmaceutical composition
11/03/2004	CN1173702C Glucocorticoid containing pharmaceutical inhalant powder and method for sterilizing the powder
11/03/2004	CN1173701C Orally disintegrating composition containing mirtazapine
11/03/2004	CN1173700C Compositions and methods for amelioration of human female sexual dysfunction
11/03/2004	CN1173699C Medicine for treating lupus erythematosus
11/03/2004	CN1173698C Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth citrate basic and ulcerlmin
11/03/2004	CN1173697C Aniline disulfide derivatives for treating allergic diseases
11/03/2004	CN1173696C Use of sibutramine analogues to lower lipid levels
11/03/2004	CN1173695C Controlled release and odor masking oral pharmaceutical compositions
11/03/2004	CN1173694C Pharmaceutical composition for treatment of acute disorders
11/03/2004	CN1173692C Cosmetic composition and method for reducing skin aging procedure
11/03/2004	CN1173685C Cosmetic compositions for the prevention and therapy of hair loss
11/02/2004	US6812364 Central nervous system disorders; psychological disorders; anticancer agents
11/02/2004	US6812362 Amidation; efficiency, higher yields, performed at or near room temperature, energy savings
11/02/2004	US6812346 Antiinflammatory agents; antipyretics; analgesics
11/02/2004	US6812344 1-(4-Arylpiperazin-1-yl)-ω-[N-(α,ω-dicarboximidoL)]-alkanes useful as uro-selective α1-adrenoceptor blockers
11/02/2004	US6812331 Aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments
11/02/2004	US6812326 Tumor necrosis factor receptor-associated factor (traf) protein-interacting hereditary multiple extoses (trex) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents
11/02/2004	US6812258 Cancer treatment composition and method using natural plant essential oils
11/02/2004	US6812257 Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity
11/02/2004	US6812256 Reducing weight in mammals; anorectic action
11/02/2004	US6812255 Use of aloe-emodin in the treatment of neuroectodermal tumors
11/02/2004	US6812254 Pain reliever and method of use
11/02/2004	US6812253 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
11/02/2004	US6812252 Acylsulfonamide derivatives containing fluorosubstitutedphenylethynyl group having a hypoglycemic effect and free of the side effect
11/02/2004	US6812251 Taurine compounds
11/02/2004	US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
11/02/2004	US6812249 Oxidation of diacetone alcohol; salt formation; enhanced physical performance
11/02/2004	US6812248 Prevention and treatment of degenerative diseases by glutathione and phase II detoxification enzymes
11/02/2004	US6812247 Used for binding or cleaving a nucleic acid
11/02/2004	US6812245 Polycylic xanthones and their use
11/02/2004	US6812244 Naphthyl compounds, intermediates, compositions, and methods of use
11/02/2004	US6812243 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation
11/02/2004	US6812241 Nitrogen-containing heterocycles having parasiticidal properties
11/02/2004	US6812237 (arylaminoaceamido)acetonitrile derivatives
11/02/2004	US6812236 Compounds useful in therapy
11/02/2004	US6812235 2-acylamino- beta -alanine derivatives and a pharmaceutically acceptable salt, useful as fibrinogen receptor antagonists
11/02/2004	US6812234 Ccr-2; inflammatory, immunoregulatory, allergic, and autoimmune disorders and diseases
11/02/2004	US6812233 Therapeutic nucleosides
11/02/2004	US6812230 Pharmaceutical compositions useful in treating progressive renal fibrosis in mammals comprising a pharmaceutically acceptable excipient and a therapeutically effective amount of a non-peptide ccr1 receptor antagonist.
11/02/2004	US6812228 Benzoxazines for use in the treatment of parkinson's disease
11/02/2004	US6812227 Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
11/02/2004	US6812226 For therapy of rheumatoid arthritis, effecting immunosuppression
11/02/2004	US6812225 Pyschological disorders; antidepressants
11/02/2004	US6812224 Phosphorous organic compounds and their use
11/02/2004	US6812223 Crystalline glucosamine sulfate metal salts and processes for preparing the same
11/02/2004	US6812220 Pharmaceutical compositions and methods relating to fucans
11/02/2004	US6812219 Methods and compositions for treating flaviviruses and pestiviruses
11/02/2004	US6812216 For therapy of bacterial infections
11/02/2004	US6812215 Compositions for the treatment of inflammatory joint diseases and osteoporosis
11/02/2004	US6812214 Use of harpagid-related compounds for prevention and treatment of osteoporosis, arthritis and ruptured disc and pharmaceutical composition containing the same
11/02/2004	US6812213 Steroidal sapogenins and their derivatives for treating alzheimer's disease
11/02/2004	US6812206 Contacting body fluid from mammal with antibody which binds to human aspartyl (asparaginyl) beta-hydroxylase (haah) polypeptide under conditions sufficient to form antigen-antibody complex and detecting complex
11/02/2004	US6812037 Antimitotic compounds
11/02/2004	US6812034 Diagnosing calcification of arteries; obtain blood sample, screen for the presence of fetuin-mineral complex in blood, amplified concentration of fetuin complex indicates calcification of arteries and other soft tissues
11/02/2004	US6811996 DDS compounds and method for assaying the same
11/02/2004	US6811975 Phosphorothioate oligonucleotides having modified internucleoside linkages
11/02/2004	US6811794 Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
11/02/2004	US6811788 Combinations and methods for treating neoplasms
11/02/2004	US6811781 Composition and method for diagnosing auto-immune hepatitis
11/02/2004	US6811779 Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
11/02/2004	US6811777 Compositions and minimally invasive methods for treating incomplete connective tissue repair
11/02/2004	US6811769 Oral composition, method of making the oral composition and oral hygiene method in japanese and chinese herbal remedy

1 ... 4907 4908 4909 4910 4911 4912 4913 4914 4915 4916 4917 4918 4919 4920 4921 4922 4923 4924 4925 4926 4927 ... 7860